Report cover image

Hereditary Transthyretin Amyloidosis Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385866

Description

Hereditary Transthyretin Amyloidosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hereditary transthyretin amyloidosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for hereditary transthyretin amyloidosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hereditary transthyretin amyloidosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Oral; Subcutaneous Injection; Other Types

2) By Drug Class: RNAi Agents (Patisiran); Small Interfering RNAs (siRNAs) (Vutrisiran)

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies

4) By Application: Hospital; Clinic; Other Applications

Subsegments:

1) By Oral: Tafamidis; Diflunisal; Experimental Oral Therapies

2) By Subcutaneous Injection: Patisiran; Inotersen; Vutrisiran

3) By Other Types: Intravenous Therapies; Gene Silencing Therapies; CRISPR-Based Therapies

Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca plc; Novo Nordisk; Regeneron Pharmaceuticals Inc.; Alexion Pharmaceuticals Inc.; Alnylam Pharmaceuticals Inc.; PTC Therapeutics Inc.; Ionis Pharmaceuticals Inc.; BridgeBio Pharma Inc.; Akcea Therapeutics; Prothena Corporation plc; Intellia Therapeutics Inc.; YoITech Therapeutics; Corino Therapeutics Inc.; Attralus Inc.; BSIM Therapeutics SA; Eidos Therapeutics; Autotac Bio Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Exanthema Market Characteristics
3. Exanthema Market Trends And Strategies
4. Exanthema Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Exanthema Growth Analysis And Strategic Analysis Framework
5.1. Global Exanthema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Exanthema Market Growth Rate Analysis
5.4. Global Exanthema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Exanthema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Exanthema Total Addressable Market (TAM)
6. Exanthema Market Segmentation
6.1. Global Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial
Viral
Other Types
6.2. Global Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Treatments
Systemic Treatments
Supportive Care
6.3. Global Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Examination
Laboratory Tests
Imaging Techniques
6.4. Global Exanthema Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rubeola
Rubella
Erythema Infectiosum
Roseola Infantum
6.5. Global Exanthema Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Speciality Centres
Other End-Users
6.6. Global Exanthema Market, Sub-Segmentation Of Bacterial Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Scarlet Fever
Meningococcemia
Staphylococcal Scalded Skin Syndrome (SSSS)
Lyme Disease
Tuberculosis-Associated Exanthema
6.7. Global Exanthema Market, Sub-Segmentation Of Viral Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Measles (Rubeola)
Rubella (German Measles)
Varicella (Chickenpox)
Roseola (Exanthem Subitum)
Hand, Foot, and Mouth Disease
Parvovirus B19 (Erythema Infectiosum / Fifth Disease)
Dengue Fever Rash
Zika Virus Rash
6.8. Global Exanthema Market, Sub-Segmentation Of Other Types of Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-Induced Exanthema (Hypersensitivity Reactions)
Autoimmune-Related Exanthema (Lupus, Kawasaki Disease)
Allergic Dermatitis-Related Exanthema
Fungal Infections Leading to Exanthema
Environmental and Toxin-Induced Exanthema
7. Exanthema Market Regional And Country Analysis
7.1. Global Exanthema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Exanthema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Exanthema Market
8.1. Asia-Pacific Exanthema Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Exanthema Market
9.1. China Exanthema Market Overview
9.2. China Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Exanthema Market
10.1. India Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Exanthema Market
11.1. Japan Exanthema Market Overview
11.2. Japan Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Exanthema Market
12.1. Australia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Exanthema Market
13.1. Indonesia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Exanthema Market
14.1. South Korea Exanthema Market Overview
14.2. South Korea Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Exanthema Market
15.1. Western Europe Exanthema Market Overview
15.2. Western Europe Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Exanthema Market
16.1. UK Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Exanthema Market
17.1. Germany Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Exanthema Market
18.1. France Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Exanthema Market
19.1. Italy Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Exanthema Market
20.1. Spain Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Exanthema Market
21.1. Eastern Europe Exanthema Market Overview
21.2. Eastern Europe Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Exanthema Market
22.1. Russia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Exanthema Market
23.1. North America Exanthema Market Overview
23.2. North America Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Exanthema Market
24.1. USA Exanthema Market Overview
24.2. USA Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Exanthema Market
25.1. Canada Exanthema Market Overview
25.2. Canada Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Exanthema Market
26.1. South America Exanthema Market Overview
26.2. South America Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Exanthema Market
27.1. Brazil Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Exanthema Market
28.1. Middle East Exanthema Market Overview
28.2. Middle East Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Exanthema Market
29.1. Africa Exanthema Market Overview
29.2. Africa Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Exanthema Market Competitive Landscape And Company Profiles
30.1. Exanthema Market Competitive Landscape
30.2. Exanthema Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
31. Exanthema Market Other Major And Innovative Companies
31.1. Serum Institute of India Pvt. Ltd.
31.2. Takeda Pharmaceutical Company Limited
31.3. Amgen Inc.
31.4. Daiichi Sankyo Company Limited
31.5. Biological E. Limited
31.6. Zydus Lifesciences Limited
31.7. Bio Farma
31.8. Meridian Bioscience Inc.
31.9. West-Ward Pharmaceutical Corp.
31.10. Trinity Biotech plc
31.11. Biosynth Srl
31.12. Creative Diagnostics
31.13. Taj Pharmaceuticals Limited
31.14. TestLine Clinical Diagnostics s.r.o.
31.15. The Native Antigen Co. Ltd.
32. Global Exanthema Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Exanthema Market
34. Recent Developments In The Exanthema Market
35. Exanthema Market High Potential Countries, Segments and Strategies
35.1 Exanthema Market In 2029 - Countries Offering Most New Opportunities
35.2 Exanthema Market In 2029 - Segments Offering Most New Opportunities
35.3 Exanthema Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.